Louise White provides an overview of the regulatory pathway to the commercialisation of drug products and outlines a framework for development groups. It also provides an introduction to the current expectations for a more scientific and risk-based approach to development and improvement across the drug product lifestyle.<br><br><br><br>DataBlitz on 'From Discovery to Clinical' was held on 1 June 2012.

Louise White provides an overview of the regulatory pathway to the commercialisation of drug products and outlines a framework for development groups. It also provides an introduction to the current expectations for a more scientific and risk-based approach to development and improvement across the drug product lifestyle. DataBlitz on 'From Discovery to Clinical' was held on 1 June 2012.

GMP and regulatory expectations in drug development (DataBlitz 2012)

This is a collection of highlights from STEM Blitz and DataBlitz - a series of monthly lunchtime peer presentations featuring three talented Swinburne researchers who will deliver a 10 minute 'taster' presentation on their research projects and/or teaching approaches.

Share GMP and regulatory expectations in drug development (DataBlitz 2012)

Sign up to save your podcasts

GMP and regulatory expectations in drug development (DataBlitz 2012)

GMP and regulatory expectations in drug development (DataBlitz 2012)